发明名称 |
FORM V CRYSTALLINE [R-(R*,R*)]-2-(4-FLUOROPHENYL)-ss, DOLLAR G(D)-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1- HEPTANOIC ACID HEMI CALCIUM SALT. (ATORVASTATIN) |
摘要 |
A novel crystalline form of [R-(R*,R*)]-2-(4-fluorophenyl)-ss, delta -dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1- heptanoic acid hemi calcium salt designated as Form V is characterized by its X-ray powder diffraction and/or solid state NMR is described, as well as methods for the preparation which is useful as an agent for treating hyperlipidemia and hypercholesterolemia.
|
申请公布号 |
WO02057229(A1) |
申请公布日期 |
2002.07.25 |
申请号 |
WO2001IN00006 |
申请日期 |
2001.01.19 |
申请人 |
BIOCON INDIA LIMITED;MATHEW, JOY;GANESH, SAMBASIVAM |
发明人 |
MATHEW, JOY;GANESH, SAMBASIVAM |
分类号 |
A61K31/40;A61P3/06;C07B61/00;C07D207/34;C07F5/02;(IPC1-7):C07D207/34 |
主分类号 |
A61K31/40 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|